BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36049661)

  • 21. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC; Yang J; Zhao W; Perez LE; Cheng J
    Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DDX3 DEAD-box RNA helicase (Hel67) gene disruption impairs infectivity of Leishmania donovani and induces protective immunity against visceral leishmaniasis.
    Pandey SC; Pande V; Samant M
    Sci Rep; 2020 Oct; 10(1):18218. PubMed ID: 33106577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening Novel Vaccine Candidates for
    Zhang J; Li J; Hu K; Zhou Q; Chen X; He J; Yin S; Chi Y; Liao X; Xiao Y; Qin H; Zheng Z; Chen J
    Front Immunol; 2022; 13():902066. PubMed ID: 35812381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteome profile of Leishmania donovani Centrin1
    Reyaz E; Tandon R; Beg MA; Dey R; Puri N; Salotra P; Nakhasi HL; Selvapandiyan A
    Microbes Infect; 2024; 26(5-6):105340. PubMed ID: 38663721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Essential Role of Neutrophils in the Protective Immune Response Induced by a Live Attenuated
    Bhattacharya P; Dey R; Saxena A; Karmakar S; Ismail N; Gannavaram S; Dagur PK; Satoskar M; Satoskar S; De Paoli S; Takeda K; McCoy JP; Nakhasi HL
    J Immunol; 2020 Dec; 205(12):3333-3347. PubMed ID: 33177159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of cross-protection by genetically modified live-attenuated Leishmania donovani parasites against Leishmania mexicana.
    Dey R; Natarajan G; Bhattacharya P; Cummings H; Dagur PK; Terrazas C; Selvapandiyan A; McCoy JP; Duncan R; Satoskar AR; Nakhasi HL
    J Immunol; 2014 Oct; 193(7):3513-27. PubMed ID: 25156362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application of rapid in vitro co-culture system of macrophages and T-cell subsets to assess the immunogenicity of dogs vaccinated with live attenuated Leishmania donovani centrin deleted parasites (LdCen-/-).
    Viana KF; Fiuza JA; Gannavaram S; Dey R; Selvapandiyan A; Bartholomeu DC; da Silveira-Lemos D; Bueno LL; Dutra WO; Fujiwara RT; Nakhasi HL; Giunchetti RC
    Parasit Vectors; 2016 Apr; 9():250. PubMed ID: 27136900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A quantitative proteomic screen to identify potential drug resistance mechanism in α-difluoromethylornithine (DFMO) resistant Leishmania donovani.
    Singh AK; Roberts S; Ullman B; Madhubala R
    J Proteomics; 2014 May; 102():44-59. PubMed ID: 24631822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
    Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
    Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-21 Expression Determines the Early Vaccine Immunity Induced by
    Gannavaram S; Bhattacharya P; Siddiqui A; Ismail N; Madhavan S; Nakhasi HL
    Front Immunol; 2019; 10():2273. PubMed ID: 31608064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis.
    Jaiswal AK; Khare P; Joshi S; Kushawaha PK; Sundar S; Dube A
    PLoS One; 2014; 9(9):e108556. PubMed ID: 25268700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of MIF gene from live attenuated LdCen
    Fiuza JA; Gannavaram S; Gaze ST; de Ornellas LG; Alves ÉA; Ismail N; Nakhasi HL; Correa-Oliveira R
    Sci Rep; 2023 May; 13(1):7362. PubMed ID: 37147351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visceral leishmaniasis: A novel nuclear envelope protein 'nucleoporins-93 (NUP-93)' from Leishmania donovani prompts macrophage signaling for T-cell activation towards host protective immune response.
    Singh MK; Jamal F; Dubey AK; Shivam P; Kumari S; Pushpanjali ; Bordoloi C; Narayan S; Das VNR; Pandey K; Das P; Singh SK
    Cytokine; 2019 Jan; 113():200-215. PubMed ID: 30001865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytosolic tryparedoxin of Leishmania donovani modulates host immune response in visceral leishmaniasis.
    Suman SS; Amit A; Singh KP; Gupta P; Equbal A; Kumari A; Topno RK; Ravidas V; Pandey K; Bimal S; Das P; Ali V
    Cytokine; 2018 Aug; 108():1-8. PubMed ID: 29554571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development.
    Volpedo G; Pacheco-Fernandez T; Bhattacharya P; Oljuskin T; Dey R; Gannavaram S; Satoskar AR; Nakhasi HL
    Front Immunol; 2021; 12():748325. PubMed ID: 34712235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The History of Live Attenuated
    Volpedo G; Bhattacharya P; Gannavaram S; Pacheco-Fernandez T; Oljuskin T; Dey R; Satoskar AR; Nakhasi HL
    Pathogens; 2022 Apr; 11(4):. PubMed ID: 35456106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Centrin-Deleted
    Singh RK; Gannavaram S; Ismail N; Kaul A; Gedda MR; Nakhasi HL
    Front Immunol; 2018; 9():1176. PubMed ID: 29915577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Live attenuated Leishmania major p27 gene knockout as a novel vaccine candidate: A study on safety, protective immunity and efficacy against canine leishmaniasis caused by Leishmania infantum.
    Elikaee S; Zarei Z; Khamesipour A; Akhoundi B; Borjian AR; Afshar MJA; Allely QK; Heidari S; Mohebali M
    Acta Trop; 2022 Jan; 225():106153. PubMed ID: 34634264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of glycolytic enzymes--rAldolase and rEnolase of Leishmania donovani, identified as Th1 stimulatory proteins, for their immunogenicity and immunoprophylactic efficacies against experimental visceral leishmaniasis.
    Gupta R; Kumar V; Kushawaha PK; Tripathi CP; Joshi S; Sahasrabuddhe AA; Mitra K; Sundar S; Siddiqi MI; Dube A
    PLoS One; 2014; 9(1):e86073. PubMed ID: 24475071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential quantitative proteomic profiling of Leishmania infantum and Leishmania mexicana density gradient separated membranous fractions.
    Lynn MA; Marr AK; McMaster WR
    J Proteomics; 2013 Apr; 82():179-92. PubMed ID: 23466312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.